Trade Getinge B - GETIb CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 1.0 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.021948% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.000275% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | SEK | ||||||||
Margin | 5% | ||||||||
Stock exchange | Sweden | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Getinge AB ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 231.3 |
Open* | 231.2 |
1-Year Change* | -4.23% |
Day's Range* | 223.1 - 231.9 |
52 wk Range | 174.20-275.20 |
Average Volume (10 days) | 736.17K |
Average Volume (3 months) | 18.58M |
Market Cap | 55.84B |
P/E Ratio | 26.60 |
Shares Outstanding | 272.37M |
Revenue | 30.42B |
EPS | 8.26 |
Dividend (Yield %) | 1.93446 |
Beta | 0.87 |
Next Earnings Date | Feb 1, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 8, 2023 | 231.3 | 0.3 | 0.13% | 231.0 | 233.4 | 227.2 |
Dec 7, 2023 | 230.6 | 0.4 | 0.17% | 230.2 | 232.7 | 229.4 |
Dec 6, 2023 | 231.0 | 4.7 | 2.08% | 226.3 | 232.3 | 226.1 |
Dec 5, 2023 | 226.4 | 1.6 | 0.71% | 224.8 | 228.6 | 224.8 |
Dec 4, 2023 | 225.8 | -0.2 | -0.09% | 226.0 | 229.0 | 225.1 |
Dec 1, 2023 | 226.8 | 3.7 | 1.66% | 223.1 | 227.4 | 223.1 |
Nov 30, 2023 | 223.6 | -2.1 | -0.93% | 225.7 | 226.3 | 221.2 |
Nov 29, 2023 | 226.1 | 5.4 | 2.45% | 220.7 | 226.6 | 220.1 |
Nov 28, 2023 | 222.0 | 1.3 | 0.59% | 220.7 | 223.3 | 220.5 |
Nov 27, 2023 | 221.3 | 0.7 | 0.32% | 220.6 | 223.7 | 220.6 |
Nov 24, 2023 | 221.4 | -0.7 | -0.32% | 222.1 | 223.4 | 220.5 |
Nov 23, 2023 | 223.2 | 3.8 | 1.73% | 219.4 | 223.8 | 219.3 |
Nov 22, 2023 | 219.3 | 2.2 | 1.01% | 217.1 | 221.4 | 216.7 |
Nov 21, 2023 | 218.6 | -0.9 | -0.41% | 219.5 | 222.0 | 217.6 |
Nov 20, 2023 | 220.2 | 1.5 | 0.69% | 218.7 | 221.5 | 218.1 |
Nov 17, 2023 | 218.7 | 1.9 | 0.88% | 216.8 | 220.3 | 215.5 |
Nov 16, 2023 | 215.8 | 0.7 | 0.33% | 215.1 | 216.7 | 213.4 |
Nov 15, 2023 | 214.7 | 2.0 | 0.94% | 212.7 | 215.9 | 212.1 |
Nov 14, 2023 | 213.5 | 6.0 | 2.89% | 207.5 | 213.9 | 207.2 |
Nov 13, 2023 | 206.7 | 0.7 | 0.34% | 206.0 | 207.2 | 204.3 |
Getinge B Events
Time (UTC) | Country | Event |
---|---|---|
Thursday, February 1, 2024 | ||
Time (UTC) 07:00 | Country SE
| Event Q4 2023 Getinge AB Earnings Release Q4 2023 Getinge AB Earnings ReleaseForecast -Previous - |
Monday, April 22, 2024 | ||
Time (UTC) 06:00 | Country SE
| Event Q1 2024 Getinge AB Earnings Release Q1 2024 Getinge AB Earnings ReleaseForecast -Previous - |
Time (UTC) 10:59 | Country SE
| Event Getinge AB Annual Shareholders Meeting Getinge AB Annual Shareholders MeetingForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 28292 | 27049 | 29819 | 26559 | 24172 |
Revenue | 28292 | 27049 | 29819 | 26559 | 24172 |
Cost of Revenue, Total | 14882 | 13469 | 15097 | 14104 | 13119 |
Gross Profit | 13410 | 13580 | 14722 | 12455 | 11053 |
Total Operating Expense | 24666 | 22678 | 25035 | 24187 | 24456 |
Selling/General/Admin. Expenses, Total | 7484 | 6972 | 7596 | 7681 | 7312 |
Research & Development | 1013 | 804 | 770 | 688 | 662 |
Depreciation / Amortization | 1074 | 1002 | 1450 | 1247 | 1009 |
Unusual Expense (Income) | 235 | 96 | 177 | 324 | 0 |
Other Operating Expenses, Total | -44 | 335 | -55 | 143 | 2354 |
Operating Income | 3626 | 4371 | 4784 | 2372 | -284 |
Interest Income (Expense), Net Non-Operating | -131 | -142 | -257 | -408 | -309 |
Other, Net | -23 | -41 | -42 | -55 | -31 |
Net Income Before Taxes | 3472 | 4188 | 4485 | 1909 | -624 |
Net Income After Taxes | 2516 | 3001 | 3272 | 1256 | -1132 |
Minority Interest | -25 | -31 | -34 | -34 | -28 |
Net Income Before Extra. Items | 2491 | 2970 | 3238 | 1222 | -1160 |
Total Extraordinary Items | 193 | ||||
Net Income | 2491 | 2970 | 3238 | 1222 | -967 |
Income Available to Common Excl. Extra. Items | 2491 | 2970 | 3239 | 1222 | -1160 |
Income Available to Common Incl. Extra. Items | 2491 | 2970 | 3239 | 1222 | -967 |
Diluted Net Income | 2491 | 2970 | 3239 | 1222 | -967 |
Diluted Weighted Average Shares | 272.37 | 272.37 | 272.37 | 272.37 | 272.37 |
Diluted EPS Excluding Extraordinary Items | 9.14565 | 10.9043 | 11.8919 | 4.48655 | -4.25892 |
Dividends per Share - Common Stock Primary Issue | 4.25 | 4 | 3 | 1.5 | 1 |
Diluted Normalized EPS | 11.5242 | 13.6509 | 14.5142 | 5.66778 | -3.9797 |
Total Adjustments to Net Income | 0 | 1 | |||
Interest Expense (Income) - Net Operating | 22 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total revenue | 7607 | 7176 | 7141 | 8499 | 6941 |
Revenue | 7607 | 7176 | 7141 | 8499 | 6941 |
Cost of Revenue, Total | 4016 | 4077 | 3622 | 4671 | 3561 |
Gross Profit | 3591 | 3099 | 3519 | 3828 | 3380 |
Total Operating Expense | 6292 | 6793 | 6240 | 7671 | 5834 |
Selling/General/Admin. Expenses, Total | 2115 | 2140 | 2061 | 2013 | 1865 |
Research & Development | 266 | 256 | 282 | 275 | 242 |
Depreciation / Amortization | 253 | 245 | 245 | 367 | 245 |
Unusual Expense (Income) | 108 | 60 | 20 | 202 | 14 |
Other Operating Expenses, Total | -466 | 15 | 10 | 143 | -93 |
Operating Income | 1315 | 383 | 901 | 828 | 1107 |
Interest Income (Expense), Net Non-Operating | -88 | -78 | -75 | -47 | -31 |
Other, Net | -1 | ||||
Net Income Before Taxes | 1227 | 305 | 826 | 781 | 1075 |
Net Income After Taxes | 901 | 217 | 593 | 561 | 805 |
Minority Interest | -7 | -2 | -7 | -5 | -7 |
Net Income Before Extra. Items | 894 | 215 | 586 | 556 | 798 |
Net Income | 894 | 215 | 586 | 556 | 798 |
Income Available to Common Excl. Extra. Items | 894 | 214 | 586 | 556 | 798 |
Income Available to Common Incl. Extra. Items | 894 | 214 | 586 | 556 | 798 |
Diluted Net Income | 894 | 214 | 586 | 556 | 798 |
Diluted Weighted Average Shares | 272.37 | 272.37 | 272.37 | 272.37 | 272.37 |
Diluted EPS Excluding Extraordinary Items | 3.2823 | 0.7857 | 2.15149 | 2.04134 | 2.92984 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 4.25 | 0 |
Diluted Normalized EPS | 2.62447 | 0.95549 | 2.21211 | 3.178 | 2.96833 |
Total Adjustments to Net Income | -1 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 19106 | 15069 | 17431 | 14494 | 14148 |
Cash and Short Term Investments | 5747 | 4078 | 6079 | 1266 | 1290 |
Cash & Equivalents | 5676 | 4076 | 6056 | 1254 | 1273 |
Short Term Investments | 71 | 2 | 23 | 12 | 17 |
Total Receivables, Net | 6703 | 5941 | 6606 | 8212 | 7988 |
Accounts Receivable - Trade, Net | 5954 | 5209 | 5854 | 7317 | 6969 |
Total Inventory | 6232 | 4767 | 4513 | 4691 | 4544 |
Prepaid Expenses | 423 | 283 | 233 | 325 | 326 |
Total Assets | 52032 | 44555 | 45014 | 44713 | 43352 |
Property/Plant/Equipment, Total - Net | 4868 | 4120 | 3973 | 4087 | 3160 |
Property/Plant/Equipment, Total - Gross | 12079 | 10493 | 9274 | 9446 | 8223 |
Accumulated Depreciation, Total | -7212 | -6372 | -5303 | -5359 | -5063 |
Goodwill, Net | 22512 | 19681 | 17427 | 18674 | 18092 |
Intangibles, Net | 4498 | 4467 | 4658 | 5609 | 6006 |
Long Term Investments | 0 | 2 | 15 | 0 | |
Note Receivable - Long Term | 50 | 52 | 50 | 32 | 80 |
Other Long Term Assets, Total | 998 | 1166 | 1473 | 1802 | 1866 |
Total Current Liabilities | 11993 | 10610 | 9788 | 9864 | 10005 |
Accounts Payable | 2252 | 1921 | 1446 | 1995 | 1868 |
Accrued Expenses | 2348 | 2608 | 2699 | 2130 | 1960 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 793 | 811 | 2519 | 2952 | 3451 |
Other Current Liabilities, Total | 6600 | 5270 | 3124 | 2787 | 2726 |
Total Liabilities | 21994 | 19805 | 23990 | 24217 | 24151 |
Total Long Term Debt | 5031 | 3495 | 7687 | 7068 | 7378 |
Long Term Debt | 4100 | 2795 | 7020 | 6487 | 7378 |
Deferred Income Tax | 1150 | 897 | 829 | 661 | 693 |
Minority Interest | 415 | 427 | 462 | 477 | 454 |
Other Liabilities, Total | 3405 | 4376 | 5224 | 6147 | 5621 |
Total Equity | 30038 | 24750 | 21024 | 20496 | 19201 |
Common Stock | 136 | 136 | 136 | 136 | 136 |
Additional Paid-In Capital | 6789 | 6789 | 6789 | 6789 | 6789 |
Retained Earnings (Accumulated Deficit) | 23113 | 17824 | 14099 | 13571 | 12276 |
Total Liabilities & Shareholders’ Equity | 52032 | 44555 | 45014 | 44713 | 43352 |
Total Common Shares Outstanding | 272.37 | 272.37 | 272.37 | 272.37 | 272.37 |
Capital Lease Obligations | 931 | 700 | 667 | 581 | |
Other Equity, Total | 1 | ||||
Other Current Assets, Total | 1 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 19394 | 18390 | 17909 | 19106 | 17671 |
Cash and Short Term Investments | 5337 | 4434 | 4625 | 5676 | 4839 |
Cash & Equivalents | 5337 | 4434 | 4625 | 5676 | 4839 |
Total Receivables, Net | 6820 | 6731 | 6497 | 7198 | 6366 |
Accounts Receivable - Trade, Net | 4510 | 4537 | 4599 | 5275 | 4435 |
Total Inventory | 7237 | 7225 | 6787 | 6232 | 6466 |
Total Assets | 53540 | 52841 | 50985 | 52032 | 51907 |
Property/Plant/Equipment, Total - Net | 5076 | 5176 | 4954 | 4868 | 4790 |
Intangibles, Net | 27962 | 28259 | 27069 | 27010 | 28327 |
Long Term Investments | 79 | 75 | 59 | 1048 | 1119 |
Total Current Liabilities | 12342 | 11457 | 10388 | 11993 | 7821 |
Accounts Payable | 2142 | 2139 | 2098 | 2252 | 1902 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 2276 | 1468 | 868 | 793 | |
Other Current Liabilities, Total | 7924 | 7850 | 7422 | 8948 | 5919 |
Total Liabilities | 21811 | 21833 | 20352 | 21994 | 21455 |
Total Long Term Debt | 4538 | 5426 | 4948 | 5031 | 5499 |
Long Term Debt | 3548 | 4390 | 3937 | 4100 | 4209 |
Capital Lease Obligations | 990 | 1036 | 1011 | 931 | 1290 |
Minority Interest | 287 | 296 | 426 | 415 | 455 |
Other Liabilities, Total | 3206 | 3468 | 3369 | 3405 | 7680 |
Total Equity | 31729 | 31008 | 30633 | 30038 | 30452 |
Common Stock | 136 | 136 | 136 | 136 | 136 |
Additional Paid-In Capital | 6789 | 6789 | 6789 | 6789 | 6789 |
Retained Earnings (Accumulated Deficit) | 24804 | 24083 | 23707 | 23113 | 23527 |
Total Liabilities & Shareholders’ Equity | 53540 | 52841 | 50985 | 52032 | 51907 |
Total Common Shares Outstanding | 272.37 | 272.37 | 272.37 | 272.37 | 272.37 |
Other Long Term Assets, Total | 1029 | 941 | 994 | ||
Deferred Income Tax | 1438 | 1186 | 1221 | 1150 | |
Other Equity, Total | 1 | 0 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | 3626 | 4371 | 4784 | 2372 | -284 |
Cash From Operating Activities | 3367 | 6560 | 7199 | 3832 | 2503 |
Cash From Operating Activities | 2027 | 1814 | 2467 | 2223 | 1808 |
Non-Cash Items | -31 | 126 | -86 | -121 | 1866 |
Cash Taxes Paid | 1012 | 693 | 553 | 357 | 366 |
Cash Interest Paid | |||||
Changes in Working Capital | -2255 | 249 | 34 | -642 | -887 |
Cash From Investing Activities | -1470 | -1329 | -1991 | -1117 | -1339 |
Capital Expenditures | -1136 | -930 | -1045 | -1220 | -1380 |
Other Investing Cash Flow Items, Total | -334 | -399 | -946 | 103 | 41 |
Cash From Financing Activities | -500 | -7237 | -297 | -2772 | -1440 |
Financing Cash Flow Items | -16 | -1 | -17 | 3 | -11 |
Total Cash Dividends Paid | -1090 | -858 | -433 | -298 | -424 |
Issuance (Retirement) of Stock, Net | 0 | ||||
Issuance (Retirement) of Debt, Net | 606 | -6378 | 153 | -2477 | -1005 |
Foreign Exchange Effects | 203 | 26 | -110 | 38 | 23 |
Net Change in Cash | 1600 | -1980 | 4801 | -19 | -253 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 901 | 3626 | 2798 | 1691 | 780 |
Cash From Operating Activities | -427 | 3367 | 2346 | 1070 | 647 |
Cash From Operating Activities | 460 | 2027 | 1332 | 875 | 438 |
Non-Cash Items | -116 | -31 | -161 | -105 | -58 |
Cash Taxes Paid | 179 | 1012 | 711 | 578 | 268 |
Changes in Working Capital | -1672 | -2255 | -1623 | -1391 | -513 |
Cash From Investing Activities | -441 | -1470 | -1088 | -551 | -262 |
Capital Expenditures | -291 | -1136 | -815 | -539 | -239 |
Other Investing Cash Flow Items, Total | -150 | -334 | -273 | -12 | -23 |
Cash From Financing Activities | -226 | -500 | -749 | -604 | -219 |
Financing Cash Flow Items | -9 | -16 | -20 | -1 | -1 |
Total Cash Dividends Paid | 0 | -1090 | -1089 | -1089 | 0 |
Issuance (Retirement) of Debt, Net | -217 | 606 | 360 | 486 | -218 |
Foreign Exchange Effects | 43 | 203 | 255 | 156 | 78 |
Net Change in Cash | -1051 | 1600 | 764 | 71 | 244 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Bennet (Carl) | Individual Investor | 14.2957 | 36332969 | -115465 | 2023-07-31 | LOW |
Fjärde AP-Fonden | Pension Fund | 8.2076 | 20859926 | -60258 | 2023-07-31 | LOW |
AMF Tjänstepension AB | Pension Fund | 5.3358 | 13561142 | -90000 | 2023-08-29 | LOW |
Swedbank Robur Fonder AB | Investment Advisor/Hedge Fund | 4.1272 | 10489417 | -112699 | 2023-09-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.1996 | 8131955 | 208996 | 2023-07-31 | LOW |
Didner & Gerge Fonder AB | Investment Advisor | 2.9673 | 7541375 | -1816866 | 2023-07-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 2.9568 | 7514786 | 52957 | 2023-07-31 | LOW |
Incentive AS | Investment Advisor/Hedge Fund | 2.8891 | 7342623 | 290008 | 2023-07-31 | LOW |
Aviva Investors Global Services Limited | Investment Advisor/Hedge Fund | 2.6 | 6608038 | 5777565 | 2023-08-31 | LOW |
Handelsbanken Kapitalförvaltning AB | Investment Advisor/Hedge Fund | 2.5639 | 6516317 | -1556103 | 2023-07-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.1717 | 5519548 | 0 | 2023-07-31 | LOW |
Carnegie Fonder AB | Bank and Trust | 2.165 | 5502395 | 1087405 | 2023-07-31 | LOW |
Folksam Group | Insurance Company | 1.9034 | 4837530 | 319711 | 2023-07-31 | LOW |
Lansförsäkringar Fondförvaltning AB | Investment Advisor | 1.2544 | 3188028 | 29615 | 2023-07-31 | LOW |
Marathon-London | Investment Advisor | 1.2049 | 3062308 | 0 | 2023-07-31 | LOW |
Storebrand Kapitalforvaltning AS | Investment Advisor | 1.0874 | 2763569 | -107812 | 2023-09-30 | LOW |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.9228 | 2345198 | -3421 | 2023-09-30 | LOW |
Lannebo Fonder AB | Investment Advisor/Hedge Fund | 0.8361 | 2125000 | 565000 | 2023-07-31 | LOW |
E.Öhman J:or Fonder AB | Investment Advisor | 0.8358 | 2124167 | 724410 | 2023-07-31 | LOW |
Cliens Asset Management AB | Investment Advisor | 0.7968 | 2025000 | -710000 | 2023-07-31 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Getinge Company profile
About Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, GetingeAB revenues decreased 9% to SEK27.05B. Net incomeapplicable to common stockholders decreased 8% to SEK2.97B.Revenues reflect a decrease in demand for the Company'sproducts and services due to unfavorable market conditions.Net income also reflects Research & Development Expenditure, Cap decrease of 19% to SEK346M (income), Acquisitionexpenses increase from SEK8M to SEK35M (expense).
Equity composition
April 2001: Bonus Issue, adjustment factor 0.9717.November 2003: Stock Split in the ratio 1:4. 02/2008,Rights Issue, 1 new share for every 16 shares held @ SEK120 (Factor: 1.014783). 11/2008, Rights Issue, 1 new sharefor every 9 shares held @ SEK 83.5 (Factor: 1.01930).
Industry: | Medical Equipment |
Lindholmspiren 7
P.O. Box 8861
GOETEBORG
VASTRA GOTALANDS 417 56
SE
Income Statement
- Annual
- Quarterly
News

December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com